Ulrik Gether
#162,959
Most Influential Person Now
Researcher
Ulrik Gether's AcademicInfluence.com Rankings
Ulrik Getherbiology Degrees
Biology
#13020
World Rank
#16537
Historical Rank
Genetics
#1435
World Rank
#1537
Historical Rank
Molecular Biology
#2154
World Rank
#2188
Historical Rank
Download Badge
Biology
Ulrik Gether's Degrees
- PhD Biology University of Copenhagen
- Masters Biology University of Copenhagen
- Bachelors Biology University of Copenhagen
Similar Degrees You Can Earn
Why Is Ulrik Gether Influential?
(Suggest an Edit or Addition)Ulrik Gether's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. (2000) (1190)
- SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation (2011) (661)
- Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* (2001) (583)
- Correlation between Genetic and Geographic Structure in Europe (2008) (485)
- G Protein-coupled Receptors (1998) (442)
- Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins (2010) (396)
- Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor (1997) (364)
- [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. (1990) (343)
- How curved membranes recruit amphipathic helices and protein anchoring motifs. (2009) (338)
- The binding sites for cocaine and dopamine in the dopamine transporter overlap (2008) (327)
- Neurotransmitter transporters: molecular function of important drug targets. (2006) (300)
- Structural Instability of a Constitutively Active G Protein-coupled Receptor (1997) (280)
- Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. (1995) (234)
- Amphipathic motifs in BAR domains are essential for membrane curvature sensing (2009) (234)
- Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. (2006) (221)
- Calmodulin Kinase II Interacts with the Dopamine Transporter C Terminus to Regulate Amphetamine-Induced Reverse Transport (2006) (219)
- Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. (1999) (217)
- The solute carrier 6 family of transporters (2012) (186)
- Delineation of an endogenous zinc‐binding site in the human dopamine transporter (1998) (186)
- Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist (1993) (185)
- N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization* (2003) (182)
- De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder (2013) (175)
- Validity of the diagnosis of a single depressive episode in a case register (2009) (163)
- Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle (2002) (156)
- A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. (1993) (150)
- Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling* (2001) (149)
- Regulation of dopamine transporter function by protein‐protein interactions: new discoveries and methodological challenges (2010) (144)
- Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase (1990) (143)
- Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. (2007) (142)
- An Intracellular Interaction Network Regulates Conformational Transitions in the Dopamine Transporter* (2008) (131)
- The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines* (2010) (128)
- Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux (2008) (128)
- Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. (1998) (125)
- Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors (2008) (122)
- Identification of Intra- and Intermolecular Disulfide Bridges in the Multidrug Resistance Transporter ABCG2* (2005) (119)
- Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. (2014) (115)
- Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD (2009) (110)
- Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. (2001) (109)
- Visualization of Dopamine Transporter Trafficking in Live Neurons by Use of Fluorescent Cocaine Analogs (2009) (108)
- Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. (1994) (108)
- Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. (1999) (107)
- The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation. (2000) (107)
- A new class of amphiphiles bearing rigid hydrophobic groups for solubilization and stabilization of membrane proteins. (2012) (105)
- Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter (1999) (105)
- Structural basis for activation of G-protein-coupled receptors. (2002) (100)
- BAR domains, amphipathic helices and membrane‐anchored proteins use the same mechanism to sense membrane curvature (2010) (95)
- Interaction between genetic polymorphisms and stressful life events in first episode depression. (2009) (93)
- The Role of Zinc Ions in Reverse Transport Mediated by Monoamine Transporters* (2002) (93)
- Surface Targeting of the Dopamine Transporter Involves Discrete Epitopes in the Distal C Terminus But Does Not Require Canonical PDZ Domain Interactions (2004) (92)
- Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding* (2004) (88)
- Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. (1993) (85)
- Water transport by the human Na+‐coupled glutamate cotransporter expressed in Xenopus oocytes (2001) (85)
- Tandem facial amphiphiles for membrane protein stabilization. (2010) (82)
- Regulation of Dopamine Transporter Trafficking by Intracellular Amphetamine (2006) (80)
- Molecular Determinants for the Complex Binding Specificity of the PDZ Domain in PICK1* (2005) (79)
- Recruitment of β-arrestin2 to the dopamine D2 receptor: Insights into anti-psychotic and anti-parkinsonian drug receptor signaling (2008) (77)
- Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter* (2012) (76)
- Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. (2019) (74)
- Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization* (2006) (71)
- Glucose-neopentyl glycol (GNG) amphiphiles for membrane protein study. (2013) (68)
- Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors (2015) (67)
- PICK1 Deficiency Impairs Secretory Vesicle Biogenesis and Leads to Growth Retardation and Decreased Glucose Tolerance (2013) (66)
- Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2 (2005) (65)
- Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains (2017) (64)
- Postendocytic Sorting of Constitutively Internalized Dopamine Transporter in Cell Lines and Dopaminergic Neurons* (2010) (62)
- Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. (1993) (61)
- The binding sites for benztropines and dopamine in the dopamine transporter overlap (2011) (60)
- Brain-derived Neurotrophic Factor (BDNF) Enhances GABA Transport by Modulating the Trafficking of GABA Transporter-1 (GAT-1) from the Plasma Membrane of Rat Cortical Astrocytes* (2011) (56)
- Passive water and urea permeability of a human Na+–glutamate cotransporter expressed in Xenopus oocytes (2002) (55)
- Differences Between Early and Late Onset Adult Depression (2011) (55)
- AMPA receptor pHluorin-GluA2 reports NMDA receptor-induced intracellular acidification in hippocampal neurons (2013) (54)
- Conformational dynamics of the human serotonin transporter during substrate and drug binding (2019) (54)
- Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1 (2007) (52)
- Membrane Localization is Critical for Activation of the PICK1 BAR Domain (2008) (52)
- Zinc Potentiates an Uncoupled Anion Conductance Associated with the Dopamine Transporter* (2004) (52)
- The Influence of Comorbid Personality Disorder and Neuroticism on Treatment Outcome in First Episode Depression (2010) (51)
- Conformational basis for the Li+‐induced leak current in the rat γ‐aminobutyric acid (GABA) transporter‐1 (2002) (46)
- The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. (1994) (46)
- Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites. (2007) (46)
- Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout (2019) (46)
- In Vivo Amphetamine Action is Contingent on αCaMKII (2014) (45)
- Protein Interacting with C Kinase 1 (PICK1) Reduces Reinsertion Rates of Interaction Partners Sorted to Rab11-dependent Slow Recycling Pathway* (2012) (43)
- A C-terminal PDZ domain binding sequence is required for striatal distribution of the dopamine transporter (2013) (42)
- Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT (2018) (41)
- Protein Interacting with C-kinase 1 (PICK1) Binding Promiscuity Relies on Unconventional PSD-95/Discs-Large/ZO-1 Homology (PDZ) Binding Modes for Nonclass II PDZ Ligands* (2014) (41)
- Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter. (2005) (41)
- Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter:Sodium Symporters* (2015) (40)
- Probing dopamine transporter structure and function by Zn2+-site engineering. (2003) (40)
- Engineered Zn(2+) switches in the gamma-aminobutyric acid (GABA) transporter-1. Differential effects on GABA uptake and currents. (2001) (39)
- Glycine Transporter Dimers (2008) (39)
- The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating. (2001) (39)
- Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected]. (1994) (38)
- An unsuspected role for organic cation transporter 3 in the actions of amphetamine (2018) (37)
- The BAR Domain Protein PICK1 Controls Vesicle Number and Size in Adrenal Chromaffin Cells (2014) (36)
- Novel tripod amphiphiles for membrane protein analysis. (2013) (36)
- Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites. (2000) (36)
- Zn2+ site engineering at the oligomeric interface of the dopamine transporter (2002) (36)
- Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons (2018) (35)
- Ligand stabilization of the beta 2 adrenergic receptor: effect of DTT on receptor conformation monitored by circular dichroism and fluorescence spectroscopy. (1996) (34)
- No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment (2010) (34)
- Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges (2019) (34)
- Transition metal ion FRET uncovers K+ regulation of a neurotransmitter/sodium symporter (2016) (33)
- Structure of Dimeric and Tetrameric Complexes of the BAR Domain Protein PICK1 Determined by Small-Angle X-Ray Scattering. (2015) (32)
- Clinical utility of Standardised Assessment of Personality - Abbreviated Scale (SAPAS) among patients with first episode depression. (2010) (32)
- Does bereavement-related first episode depression differ from other kinds of first depressions? (2010) (32)
- Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1. (2010) (32)
- Stable expression of high affinity NK1 (substance P) and NK2(neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells (1992) (31)
- Neuropsychiatric disease–associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes (2018) (31)
- Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter* (2015) (30)
- Use of fluorescence spectroscopy to study conformational changes in the beta 2-adrenoceptor. (2002) (30)
- The Second Sodium Site in the Dopamine Transporter Controls Cation Permeation and Is Regulated by Chloride* (2014) (29)
- An Amphipathic Helix Directs Cellular Membrane Curvature Sensing and Function of the BAR Domain Protein PICK1. (2018) (29)
- Conserved HisVI‐17 of the NK‐1 receptor is involved in binding of non‐peptide antagonists but not substance P (1993) (29)
- Evidence for Distinct Sodium-, Dopamine-, and Cocaine-dependent Conformational Changes in Transmembrane Segments 7 and 8 of the Dopamine Transporter* (2003) (28)
- X-ray structure of LeuT in an inward-facing occluded conformation reveals mechanism of substrate release (2020) (28)
- Do stressful life events predict medical treatment outcome in first episode of depression? (2009) (28)
- Examining the efficiency of receptor/G‐protein coupling with a cleavable β2‐adrenoceptor–Gsα fusion protein (1999) (27)
- Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling (1998) (27)
- The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway (2017) (27)
- Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor (1992) (27)
- Membrane-permeable C-terminal Dopamine Transporter Peptides Attenuate Amphetamine-evoked Dopamine Release* ♦ (2013) (26)
- The Serotonin Transporter Undergoes Constitutive Internalization and Is Primarily Sorted to Late Endosomes and Lysosomal Degradation* (2014) (25)
- The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter (2020) (24)
- Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor. (1994) (24)
- The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression—A randomised trial (2012) (23)
- Amphetamine Action at the Cocaine- and Antidepressant-Sensitive Serotonin Transporter Is Modulated by αCaMKII (2015) (22)
- PICK1 expression in the Drosophila central nervous system primarily occurs in the neuroendocrine system (2009) (22)
- Zn2+ modulation of neurotransmitter transporters. (2006) (22)
- Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter* (2001) (22)
- A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation (2009) (21)
- Serotonin-induced down-regulation of cell surface serotonin transporter (2014) (21)
- Conformational Dynamics on the Extracellular Side of LeuT Controlled by Na+ and K+ Ions and the Protonation State of Glu290* (2016) (20)
- Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer (2017) (20)
- Elucidating Conformational Changes in the γ-Aminobutyric Acid Transporter-1* (2009) (19)
- A high‐affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain (2020) (17)
- Cat pancreatic eicosapeptide and its biosynthetic intermediate. Conservation of a monobasic processing site. (1986) (16)
- Akt-mediated regulation of antidepressant-sensitive serotonin transporter function, cell-surface expression and phosphorylation. (2015) (16)
- Structure–activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5‐HT transporter (2016) (16)
- High-performance liquid chromatography of phenylthiocarbamyl derivatives of amino acids and side-chain derivatized amino acids. (1987) (16)
- Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram. (2014) (15)
- Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals (2020) (15)
- A fluorescence polarization based screening assay for identification of small molecule inhibitors of the PICK1 PDZ domain. (2011) (15)
- Gender Differences among Patients with a Single Depressive Episode (2010) (15)
- The Effect of pH on β2 Adrenoceptor Function (2000) (15)
- Direct assessment of substrate binding to the Neurotransmitter:Sodium Symporter LeuT by solid state NMR (2017) (15)
- Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial (2012) (14)
- Rab2 drives axonal transport of dense core vesicles and lysosomal organelles (2020) (14)
- Serine 77 in the PDZ domain of PICK1 is a protein kinase Cα phosphorylation site regulated by lipid membrane binding. (2012) (14)
- Preserved dopaminergic homeostasis and dopamine‐related behaviour in hemizygous TH‐Cre mice (2017) (14)
- The Environment Shapes the Inner Vestibule of LeuT (2016) (14)
- Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients – A Randomized Placebo-Controlled Trial (2011) (14)
- PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis (2018) (13)
- Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake. (2017) (13)
- A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity (2015) (13)
- Differential effects of chemogenetic inhibition of dopamine and norepinephrine neurons in the mouse 5-choice serial reaction time task (2019) (13)
- Molecular mechanism of activation and inhibition of 7TM peptide receptors (1994) (13)
- PreproVIP‐derived peptides in tissue and plasma from patients with VIP‐producing tumours (1991) (13)
- Efficient amidation of C-peptide deleted NPY precursors by non-endocrine cells is affected by the presence of Lys-Arg at the C-terminus (1993) (13)
- Residues in the Extracellular Loop 4 Are Critical for Maintaining the Conformational Equilibrium of the γ-Aminobutyric Acid Transporter-1* (2003) (13)
- Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini* (2016) (13)
- Comparison of peptidyl-glycine α-amidation activity in medullary thyroid carcinoma cells, pheochromocytomas, and serum (1991) (12)
- Mechanisms of PDZ domain scaffold assembly illuminated by use of supported cell membrane sheets (2018) (12)
- Glucose-Neopentyl Glycol (GNG) Amphiphiles for Membrane Protein Solubilization, Stabilization and Crystallization (2013) (11)
- Purification and fluorescent labeling of the human serotonin transporter. (2005) (11)
- Tachykinin non-peptide antagonists: binding domain and molecular mode of action. (1995) (10)
- Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy. (1998) (10)
- Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8 (2005) (10)
- An evaluation of the genetic-matched pair study design using genome-wide SNP data from the European population (2009) (10)
- Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task (2017) (10)
- Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. (1998) (10)
- Fluorescent Labeling of Purified β2 Adrenergic Receptor (1995) (9)
- Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor. (1999) (9)
- Tyrosylation and purification of peptides for radioiodination. (1988) (9)
- Chemogenetic Targeting of Dorsomedial Direct-pathway Striatal Projection Neurons Selectively Elicits Rotational Behavior in Mice (2019) (9)
- Examination of ligand-induced conformational changes in the beta2 adrenergic receptor. (1998) (9)
- Reliability of clinical ICD-10 diagnoses among electroconvulsive therapy patients with chronic affective disorders (2008) (8)
- Genome-Wide Association Study of Genetic Variants in LPS-Stimulated IL-6, IL-8, IL-10, IL-1ra and TNF-α Cytokine Response in a Danish Cohort (2013) (7)
- Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression (2012) (7)
- Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent (2020) (7)
- Ligand Stabilization of the â 2 Adrenergic Receptor : Effect of DTT on Receptor Conformation Monitored by Circular Dichroism and Fluorescence Spectroscopy † (7)
- Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sites. (2001) (7)
- Novel Fluorescent Ligands Enable Single-Molecule Localization Microscopy of the Dopamine Transporter. (2020) (7)
- Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene (2013) (7)
- Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity (2022) (6)
- Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopy. (2003) (6)
- Initial rewarding effects of cocaine and amphetamine assessed in a day using the single‐exposure place preference protocol (2018) (6)
- No effect of escitalopram versus placebo on brain-derived neurotrophic factor in healthy individuals: a randomised trial (2015) (6)
- A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression (2011) (6)
- Subjective perception of cocaine reward in mice assessed by a single exposure place preference (sePP) paradigm (2017) (5)
- Engineered Zn Switches in the -Aminobutyric Acid (GABA) Transporter-1 DIFFERENTIAL EFFECTS ON GABA UPTAKE AND CURRENTS* (2001) (5)
- Structural basis of organic cation transporter-3 inhibition (2022) (5)
- A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function (2016) (5)
- Genome-wide association study of genetic variants in LPS-stimulated IL-6, IL-8, IL-10, IL-1ra and TNF- cytokine response in a Danish Cohort (2013) (5)
- Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression – a secondary outcome analysis from the randomized AGENDA trial (2016) (5)
- Glycine transporter dimers: evidence for occurrence in the plasma membrane. (2022) (5)
- Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research. (2017) (4)
- Examining the efficiency of receptor/G-protein coupling with a cleavable beta2-adrenoceptor-gsalpha fusion protein. (1999) (4)
- Copy number variations in affective disorders and meta-analysis (2011) (4)
- Engineered Zn2+ Switches in the γ-Aminobutyric Acid (GABA) Transporter-1 (2001) (4)
- Agonist-Induced Conformational Changes at the Cytoplasmic Side of TM 6 in the ß2 Adrenergic Receptor Mapped by Site-Selective Fluorescent Labeling (2000) (4)
- Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease (2021) (4)
- Assessing adrenergic receptor conformation using chemically reactive fluorescent probes. (2000) (3)
- Adaptive aspects of impulsivity and interactions with effects of catecholaminergic agents in the 5-choice serial reaction time task: implications for ADHD (2021) (3)
- Processing or inactivation of antimicrobial peptides (1987) (3)
- The Scaffold Protein PICK1 as a Target in Chronic Pain (2022) (3)
- Behavioral encoding across timescales by region-specific dopamine dynamics (2022) (3)
- Introducing tetraCys motifs at two different sites results in a functional dopamine transporter. (2009) (3)
- Disruption of the PDZ domain–binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation (2021) (3)
- G protein‐coupled receptor pharmacology—The next generation (2020) (2)
- Structural biology: Antidepressants at work (2016) (2)
- Molecular Mechanism of Action of Non-peptide Ligands for Peptide Receptors (1995) (2)
- Dopaminergic neurons establish a distinctive axonal arbor with a majority of non‐synaptic terminals (2021) (2)
- Dissociating reward sensitivity and negative urgency effects on impulsivity in the five-choice serial reaction time task (2022) (2)
- David versus Goliath. (2010) (2)
- Screening the Sensing of Membrane Curvature by BAR domains on Single Liposome Arrays (2009) (2)
- Erratum: Glucose-Neopentyl Glycol (GNG) amphiphiles for membrane protein study (Chemical Communications (2013) 49 (2287-2289) DOI: 10.1039/c2cc36844g) (2013) (1)
- The common non-peptide antagonist binding domain of the NK-1 receptor (1994) (1)
- Correction: Corrigendum: A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter (2013) (1)
- Coding variants identified in diabetic patients alter PICK1 BAR domain function in insulin granule biogenesis (2020) (1)
- Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors (2021) (1)
- Reply to Wilkinson et al.: Concerning the use of pHluorin-tagged GluA2 as a reporter for NMDA-induced AMPA receptor recycling (2014) (1)
- Molecular Mechanisms of GPCR Activation (2006) (1)
- Supplemental Information Structure of Dimeric and Tetrameric Complexes of the BAR Domain Protein PICK 1 Determined by Small-Angle X-Ray Scattering (1)
- Missense mutations in the dopamine transporter gene associate with adult parkinsonism and ADHD Supplementary Information (2014) (1)
- A density-based enrichment measure for assessing colocalization in single-molecule localization microscopy data (2022) (1)
- Erratum: A new class of amphiphiles bearing rigid hydrophobic groups for solubilization and stabilization of membrane protein (Chemistry - A European Journal (2012) 31) (2013) (1)
- A classifier driven approach to find biomarkers for affective disorders from transcription profiles in blood (2016) (1)
- Calmodulin kinase II regulates amphetamine-induced reverse transport in dopamine and serotonin transporters (2012) (1)
- A virtual high-throughput screening approach to the discovery of novel inhibitors of the bacterial leucine transporter, LeuT (2013) (1)
- Correction to “Tandem Facial Amphiphiles for Membrane Protein Stabilization” (2013) (0)
- It takes two—or more—to tango: Revisiting the role of dopamine transporter oligomerization (2021) (0)
- Partial Unwinding of Transmembrane Helices Facilitates Alternating Access in the Neurotransmitter:Sodium Symporter LeuT (2017) (0)
- Structure of Dimeric and T etrameric Complexes of the BAR Domain Protein PICK 1 Determined by Small-Angle X-Ray Scattering Graphical (2015) (0)
- Obituary (1902) (0)
- Author response: Direct assessment of substrate binding to the Neurotransmitter:Sodium Symporter LeuT by solid state NMR (2016) (0)
- Structure of the PICK PDZ domain in complex with the DAT C-terminal (2013) (0)
- The dopamine transporter: genetic mouse models, psychostimulant addiction and neuropsychiatric disorders (358.3) (2014) (0)
- Mechanism of substrate release in neurotransmitter:sodium symporters: the structure of LeuT in an inward-facing occluded conformation (2020) (0)
- Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains (2017) (0)
- Calmodulin kinase II regulates amphetamine-induced reverse transport in dopamine and serotonin transporters (2012) (0)
- Report and Geographic Structure in Europe (0)
- Inside Cover: A New Class of Amphiphiles Bearing Rigid Hydrophobic Groups for Solubilization and Stabilization of Membrane Proteins (Chem. Eur. J. 31/2012) (2012) (0)
- Conformational dynamics of the human serotonin transporter during substrate and drug binding (2019) (0)
- Within-Mice Comparison of Microdialysis and Fiber Photometry-Recorded Dopamine Biosensor during Amphetamine Response (2023) (0)
- Disrupted PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation (2021) (0)
- A dominant-negative variant in the dopamine transporter PDZ-binding motif is linked to parkinsonism and neuropsychiatric disease (2020) (0)
- GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity (2023) (0)
- Elucidating the Mechanism Behind Sodium-Coupled Neurotransmitter Transporters by Reconstitution (2021) (0)
- Dopamine Transporter Knock-In Mice with a Disrupted PDZ-Protein Binding Motif Display Hyperactivity and Could be Insensitive to Amphetamine (2009) (0)
- Session 1: The Receptors of Neuropeptides: Ligand-receptor Interactions (1994) (0)
- Elucidating the Mechanism Behind Sodium-Coupled Neurotransmitter Transporters by Reconstitution (2021) (0)
- CA 2+ /CALMODULIN-DEPENDENT KINASE II- ASSOCIATES WITH THE C TERMINUS OF THE DOPAMINE TRANSPORTER AND INCREASES AMPHETAMINE-INDUCED DOPAMINE EFFLUX VIA PHOSPHORYLATION OF N-TERMINAL SERINES (2005) (0)
- Phosphorylation of the Amphipathic Helix Changes the Lipid Binding Capacities of PICK1 (2013) (0)
- DimerX Peptide Presentation Technology (continued from cover) (2001) (0)
- Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations (2022) (0)
- Design and Characterization of Small Molecule Inhibitors of the PICK1 PDZ Domain with Binding Free Energy Calculations (2010) (0)
- Avidity of Scaffolding Interactions Studied on Inverted Membrane Sheets Using the Synaptic Scaffolding Protein PICK1 (2013) (0)
- NEUROTRANSMITTER TRANSPORTERS : BASAL FUNCTION AND DRUG TARGETS AUGUST 9-12 , 2004 , COPENHAGEN , DENMARK Organizing committee : (2011) (0)
- Biochemical and Biophysical Studies of Membrane Deformation by Bar-Domain Proteins (2013) (0)
- Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK 1 and NK 2 receptors ( substance P / neuroklnin A / CP 96 , 345 / SR 48 , 968 ) (2005) (0)
- G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization (2019) (0)
- (Leu31,Pro34)Neuropeptide Y: A specific Yi receptor agonist (peptide receptors/cytoplasmic free calcium/vasoactive peptides/blood pressure) (2016) (0)
- Mechanistic Characterization of the Allosteric Communications between the Central Binding Site and the Extracellular Vestibule of the Serotonin Transporter (2019) (0)
- X-ray structure of LeuT in an inward-facing occluded conformation reveals mechanism of substrate release (2020) (0)
- P0028 - Are life events prior to first episode of major depression a predictor of medical treatment outcome? (2008) (0)
- Fluorescence correlation spectroscopy (FCS) analysis of the purified human serotonin transporter (2001) (0)
- Conformational Dynamics of Lipid-Reconstituted LeuT Studied at the Single Vesicle and Single Molecule Level (2012) (0)
- The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter (2020) (0)
- Insights From Endogenous and Engineered Zn2+ Binding Sites in Monoamine Transporters (2004) (0)
- S5-3 The structure and function of the tachykinin receptors (1993) (0)
- System: Mechanisms and Functions Neurotrophin-Mediated Rapid Signaling in the Central Nervous (2012) (0)
- Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor (1992) (0)
- Substrate‐dependent conformational changes in the Na+/Cl−/GABA cotransporter (GAT‐1) studied by cysteine‐accessibility and voltage‐clamp fluorometry (2006) (0)
- Missense mutations in the dopamine transporter gene: commonality between neuropsychiatric and neurodegenerative diseases? (2016) (0)
- [Optogenetics brings hidden neural mechanisms into the light and could become a future therapy]. (2015) (0)
- P0029 - Genetic Polymorphisms and the outcome of antidepressant Treatment (2008) (0)
- Direct-Pathway Spiny Projection Neuron Inhibition Evokes Transient Circuit Imbalance Manifested as Rotational Behavior (2020) (0)
- Within-animal comparison of microdialysis and fiber photometry in amphetamine-exposed mice (2022) (0)
- Relative enrichment – a density-based colocalization measure for single-molecule localization microscopy (2022) (0)
- Coding variants identified in patients with diabetes alter PICK1 BAR domain function in insulin granule biogenesis (2022) (0)
This paper list is powered by the following services:
Other Resources About Ulrik Gether
What Schools Are Affiliated With Ulrik Gether?
Ulrik Gether is affiliated with the following schools:
